A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/28/2006	WO2006012492A8 Compositions and methods for viscosupplementation
12/28/2006	WO2006009967A3 Novel ester as useful broad spectrum fungicidal compounds
12/28/2006	WO2006009702A3 Liver disease-related methods and systems
12/28/2006	WO2006003518A3 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract
12/28/2006	WO2006002437A3 Treatment of conditions involving demyelination
12/28/2006	WO2006000923A3 Macrolide compositions as therapeutic agent
12/28/2006	WO2005123192A3 Improving pain treatment with strontium combinations
12/28/2006	WO2005123093A3 Ophthalmic formulations including selective alpha 1 antagonists
12/28/2006	WO2005122678A3 A pharmaceutical composition having prokinetic effect and comprising o-(3-piperidino-2-hydroxypropyl) nicotinic amidoxime
12/28/2006	WO2005110489A3 Nucleic acid aptamers conjugated to high molecular weight steric groups
12/28/2006	WO2005107751A8 Methods for treating arthritic conditions in dogs
12/28/2006	WO2005104711A3 Purification of progesterone receptor modulators
12/28/2006	WO2005097193A3 Sequential sprm/progestin treatment
12/28/2006	WO2005094796A3 Methods for interfering with fibrosis
12/28/2006	WO2005087752A8 Substituted hydroxyethylamine aspartyl protease inhibitors
12/28/2006	WO2005084712A3 Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment
12/28/2006	WO2005080358A3 Rosiglitazone phosphate and polymorphic forms
12/28/2006	WO2005079525A3 A method for the production of transgenic proteins useful in the treatment of obesity and diabetes
12/28/2006	WO2005041904A3 Inhibitors of coronavirus protease and methods of use thereof
12/28/2006	WO2005025536A8 Dry powder composition comprising co-jet milled particles for pulmonary inhalation
12/28/2006	WO2004020599A3 Hedgehog antagonists, methods and uses related thereto
12/28/2006	WO2004003138A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/28/2006	US20060294604 Model for studying the role of genes in tumor resistance to chemotherapy
12/28/2006	US20060294601 Compositions, organisms and methodologies employing a novel human kinase
12/28/2006	US20060293543 Isolation of lutein from alfalfa
12/28/2006	US20060293527 Analogs of epothilone
12/28/2006	US20060293519 Method for producing cyclic diamine derivative or salt thereof
12/28/2006	US20060293517 Enantiomerically pure cilazapril, process for preparation
12/28/2006	US20060293514 Nucleotide lipid ester derivatives
12/28/2006	US20060293395 Methods for treating a mammal before, during and after cardiac arrest
12/28/2006	US20060293394 Combretastatin analogs with tubulin binding activity
12/28/2006	US20060293393 Iptakalim hydrochloride for decreasing nicotine use
12/28/2006	US20060293392 Benzamide derivatives and uses related thereto
12/28/2006	US20060293391 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
12/28/2006	US20060293390 Diflunisal for the treatment of cancer
12/28/2006	US20060293389 Process for producing injectable gabapentin compositions
12/28/2006	US20060293388 Pomolic acid, its isomers, derivatives and their uses, pharmaceutical composition, method to prepare the pharmaceutical composition and method for treating multidrug resistant tumours
12/28/2006	US20060293387 Agent for lowering neutral fat concentration in blood
12/28/2006	US20060293386 Method for treating cancer
12/28/2006	US20060293385 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; 2-(4-{1-Ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-2-methyl-benzoylamino)-2-methyl-propionic acid
12/28/2006	US20060293384 Isethionyl nitrates and compounds thereof
12/28/2006	US20060293383 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
12/28/2006	US20060293382 Stable warfarin sodium liquid formulation and method of making same
12/28/2006	US20060293381 Fungicidal effect by regulating signal transduction pathways
12/28/2006	US20060293380 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
12/28/2006	US20060293379 chemoattractant cytokine receptor 2 (CCR2) antagonists such as {4-[(3-bromo-8,9-dihydro-7H-benzocycloheptene-6-carbonyl)-amino]-benzyl}-cyclohexyl-dimethyl-ammonium iodide, useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases; antiinflammatory agents
12/28/2006	US20060293378 Method of lowering intraocular pressure
12/28/2006	US20060293377 Amorphous and polymorphic forms of telmisartan sodium
12/28/2006	US20060293376 Benzopyran derivatives substituted with a benzimidazole derviative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
12/28/2006	US20060293375 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases
12/28/2006	US20060293374 Substituted isothiazolones
12/28/2006	US20060293372 Beta-sheet mimetics and methods relating to the use thereof
12/28/2006	US20060293371 Prodrug and process for producing the same
12/28/2006	US20060293370 Sulfonamide compounds and uses thereof
12/28/2006	US20060293368 Amorphous N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide hydrochloride
12/28/2006	US20060293367 Amorphous N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide
12/28/2006	US20060293366 Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
12/28/2006	US20060293365 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
12/28/2006	US20060293364 Niacin receptor agonists, compositions containing such compounds and methods of treatment
12/28/2006	US20060293363 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles
12/28/2006	US20060293362 Nitro-substituted hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
12/28/2006	US20060293361 Compounds
12/28/2006	US20060293360 4-(2-Phenyloxyphenyl)-piperidine or-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
12/28/2006	US20060293359 Methods and compositions for the treatment of diabetes
12/28/2006	US20060293358 Tyrosine kinase inhibitors
12/28/2006	US20060293357 Chemical intermediates for indole alkaloids, formed by cyclization of thioanilides, then chlorination of indole derivatives with t-butylhypochlorite, coupling vindolines, deacetylation and desulfonation; anticarcinogrnic agents
12/28/2006	US20060293356 Methods for treating smooth muscle contractions using trospium
12/28/2006	US20060293355 Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s)-3, 5-dihydroxyhept-6-enoicacid] calcium salt
12/28/2006	US20060293354 Pyrimidine derivatives and their use as CB2 modulators
12/28/2006	US20060293353 Matrix metalloproteinase inhibitors
12/28/2006	US20060293352 Phenoxiacetic acid derivatives
12/28/2006	US20060293351 Promotion of wound healing
12/28/2006	US20060293350 such as 8-methoxy-4-methyl-3,4-dihydro-quinazolin-2-ylamine, serotonin receptor antagonists used for the treating schizophrenia, sexual dysfunction, obsessive compulsive, post-traumatic stress, sleep, eating, gastrointestinal and psychological disorders, as anxiolytic agents, antidepressants, analgesics
12/28/2006	US20060293349 5-Chloro-4-alkyl-3,4-dihydro-quinazolin-2-ylamine derivatives
12/28/2006	US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/28/2006	US20060293347 Pharmaceutically active compounds
12/28/2006	US20060293345 Heterobicyclic metalloprotease inhibitors
12/28/2006	US20060293344 Viricide against herpes virus; a pyrazolo[1,5- alpha]pyridinyl compounds; chemical synthesis
12/28/2006	US20060293343 Pyrimidine derivatives
12/28/2006	US20060293342 Tie-2 modulators and methods of use
12/28/2006	US20060293341 Alkyl sulfonamide derivatives
12/28/2006	US20060293340 2-Aminopyrimidine derivatives as raf kinase inhibitors
12/28/2006	US20060293339 Biaryl substituted 6-membered heterocycles as sodium channel blockers
12/28/2006	US20060293338 protein serine/threonine kinase inhibitors such as 2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one, used for treating autoimmune diseases, HIV, cancer, anemia myelodysplastic syndrome and thrombocytopenia
12/28/2006	US20060293337 P2x7 receptor antagonists and their use
12/28/2006	US20060293336 C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
12/28/2006	US20060293335 Riboflavin derivative and its manufacture and uses
12/28/2006	US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase
12/28/2006	US20060293333 Therapeutic amides
12/28/2006	US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists
12/28/2006	US20060293331 Process of synthesizing tadalafil
12/28/2006	US20060293330 Hiv replication inhibiting purine derivatives
12/28/2006	US20060293329 such as alpha -[(3-azabicyclo[3.3.0]octyl-3-amino)methylene]-N-(4-chlorophenyl)-3-methyl-5-isoxazoleacetamide, allosteric modulators of alpha 7 nicotinic acetylcholine receptor; central nervous system disorders, sleep disorders, neurodegenerative disorders
12/28/2006	US20060293328 Linear dicationic terphenyls and their aza analogues as antiparasitic agents
12/28/2006	US20060293327 Composition containing medicine extremely slightly soluble in water being excellent in eluting property and method for preparation thereof
12/28/2006	US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/28/2006	US20060293325 Glyceraldehyde 3-phosphate dehydrogenase (GADPH) inhibitors and screening compounds
12/28/2006	US20060293324 Pyrimidine compounds
12/28/2006	US20060293323 Therapeutic Combinations of erb B Kinase Inhibitors and Antineoplastic Therapies
12/28/2006	US20060293322 For therapy of lung and breast cancer

1 ... 3945 3946 3947 3948 3949 3950 3951 3952 3953 3954 3955 3956 3957 3958 3959 3960 3961 3962 3963 3964 3965 ... 7860